Journal
ACTA BIOMATERIALIA
Volume 10, Issue 3, Pages 1354-1359Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.actbio.2013.12.021
Keywords
Inclusion bodies; Protein release; Drug delivery; Nanomedicine; Surface functionalization
Funding
- CIBER de Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN, Spain)
- VI National RDi Plan
- Iniciativa Ingenio
- Consolider Program
- CIBER Actions
- Instituto de Salud Carlos III
- MINECO [BFU2010-17450]
- AGAUR [2009SGR-0108]
- ICREA ACADEMIA award
Ask authors/readers for more resources
Bacterial inclusion bodies (IBs) have recently been used to generate biocompatible cell culture interfaces, with diverse effects on cultured cells such as cell adhesion enhancement, stimulation of cell growth or induction of mesenchymal stem cell differentiation. Additionally, novel applications of IBs as sustained protein delivery systems with potential applications in regenerative medicine have been successfully explored. In this scenario, with IBs gaining significance in the biomedical field, the fine tuning of this functional biomaterial is crucial. In this work, the effect of temperature on fibroblast growth factor-2 (FGF-2) IB production and performance has been evaluated. FGF-2 was overexpressed in Escherichia coli at 25 and 37 degrees C, producing IBs with differences in size, particle structure and biological activity. Cell culture topographies made with FGF-2 IBs biofabricated at 25 degrees C showed higher levels of biological activity as well as a looser supramolecular structure, enabling a higher protein release from the particles. In addition, the controlled use of FGF-2 protein particles enabled the generation of functional topographies with multiple biological activities being effective on diverse cell types. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available